Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › SGLT2 inhibitor

SGLT2 inhibitor

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of SGLT2 inhibitor

7 trials tracked of SGLT2 inhibitor: 6 in phase 3 or 4 and 5 with published results. The most-cited published study has 259 citations.

7Trials tracked
6Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 2 Phase 3 4 Other / NA 1
  1. Phase 3 A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus Completed · 259 cited
  2. Phase 3 A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes Completed · 69 cited
  3. Phase 4 Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE Completed · 16 cited
  4. Phase 3 The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. Completed · 13 cited
  5. Phase 4 Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency Completed · 2 cited
  6. Phase 3 iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) Completed
Show 1 more trials
  1. N/A Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Review of observational data links semaglutide and tirzepatide to survival in breast cancer
Oncology
Review of observational data links semaglutide and tirzepatide to survival in breast cancer Semaglutide linked to lower death rates in breast cancer patients compared to other diabetes drugs
This review synthesized observational, propensity-matched analyses of patients with pre-existing breast cancer.
In routine care, semaglutide users with breast cancer had significantly lower death rates and less metastatic disease than those on other co…
medRxiv Apr 24, 2026
Meta-analysis finds SGLT2 inhibitors reduce mortality and hospitalization in older heart failure patients
Cardiology Meta-analysis
Meta-analysis finds SGLT2 inhibitors reduce mortality and hospitalization in older heart failure patients Older Adults With Heart Failure May Gain Years From This Pill
A systematic review and meta-analysis of 20,844 patients aged 65+ with heart failure found SGLT2 inhibitors were associated with reduced all…
A pooled look at 10 studies in over 20,000 older adults shows SGLT2 inhibitors cut the risk of dying from any cause by about a fifth — and t…
Apr 9, 2026